Driving market access readiness in the US through a unique digital application

What US market access teams should know about digital transformation.

In this digital transformation update, Nicole Lodowski, Senior Director and PRMA US Practice Lead, explains the need to understand payer specific value drivers in the US, and how these can be leveraged to understand market access opportunities and risks to develop a robust evidence generation plan.

Download this free market access paper to learn:

  • What dynamics make the US unique to other markets?
  • Why must manufacturers use differential approaches when identifying risks, opportunities, and evidence needs across different US payer archetypes?
  • How PRMA Healthcheck® US framework provides a robust and complete perspective of the US payer landscape.

FREE Article

Driving market access readiness in the US through a unique digital application

We respect your privacy. Cookie policy.

Latest insights

Driving BioPharma Access in Europe: Insights for ...

PRMA Consulting becomes Avalere Health, creating the ...

World Orphan Drug Congress 2023: solutions for market ...